<ѻýҕl>Older Men Still Overscreened for Prostate Cancer, Survey Saysѻýҕl> PSA screening rates over 50% for men 70 and up, despite USPSTF recommendations against it Apr 11, 2023
<ѻýҕl>FDA Greenlights New First-Line Regimen in Bladder Cancerѻýҕl> Enfortumab vedotin plus pembrolizumab approved for cisplatin-ineligible patients Apr 04, 2023
<ѻýҕl>Post-Immunotherapy Combo Promising in Advanced RCCѻýҕl> Duration of response reaches 18.6 months with belzutifan plus cabozantinib Apr 03, 2023
<ѻýҕl>Neuromodulation of the Peroneal Nerve Safe for Overactive Bladderѻýҕl> Was also as effective as solifenacin in the majority of assessed efficacy endpoints Mar 24, 2023
<ѻýҕl>Treating Gender Nonconforming Youth Goes Beyond the Physicalѻýҕl> We must approach care for every patient from the lens of treating the entire individual Mar 15, 2023
<ѻýҕl>Gender-Affirming Surgery Gets a Boost After California Law Kicked Inѻýҕl> Nondiscrimination law bars insurers from limiting benefits based on gender identity, expression Mar 14, 2023
<ѻýҕl>Novel PET Imaging Agent Accurately IDs Clear Cell Renal Cancersѻýҕl> ZIRCON trial meets sensitivity and specificity targets Mar 13, 2023
<ѻýҕl>A Surge in Vasectomies: Sustaining the Demandѻýҕl> To increase participation, let's reduce the points of friction Mar 13, 2023
<ѻýҕl>Daily Thiazide No Help in Preventing Recurrent Kidney Stonesѻýҕl> Three different dosages of hydrochlorothiazide no better than placebo Mar 01, 2023
<ѻýҕl>Combo Falters in Papillary Renal Cancer, but Some Promise in MET-Driven Subsetѻýҕl> Over 50% of patients with advanced MET-driven tumors responded to savolitinib plus durvalumab Feb 24, 2023
<ѻýҕl>FDA OKs Sparsentan for IgA Nephropathy-Related Proteinuriaѻýҕl> Non-immunosuppressive therapy led to 50% reduction in proteinuria Feb 21, 2023
<ѻýҕl>Pembrolizumab Active in BCG-Unresponsive Papillary High-Risk Bladder Cancerѻýҕl> KEYNOTE-057 trial results suggest DFS benefit for patient population with unmet need Feb 19, 2023
<ѻýҕl>Escalated ADT Falls Short in Men With High-Risk Features After Prostatectomyѻýҕl> But add-on abiraterone and apalutamide may offer some benefits in those with higher PSA Feb 18, 2023
<ѻýҕl>Add-On Olaparib Continues to Show Benefit in First-Line Treatment of mCRPCѻýҕl> Final PROpel analysis also shows trend toward overall survival improvement with PARP inhibitor Feb 17, 2023
<ѻýҕl>Adding Talazoparib to Enzalutamide Boosts PFS in Metastatic Prostate Cancerѻýҕl> Combination achieved a 37% reduction in risk of progression, death versus ARPI alone Feb 17, 2023
<ѻýҕl>Rucaparib Gets a Win in Metastatic Castration-Resistant Prostate Cancerѻýҕl> Benefit in selected patients seen over physician's choice of docetaxel or second-generation ARPI Feb 16, 2023
<ѻýҕl>If It Resembles Cancer but Doesn't Act Like Cancer, Is It Cancer?ѻýҕl> Physicians must consider patient perspectives on the Gleason 6 debate Feb 16, 2023
<ѻýҕl>Hormone Infusion Shows Promise for Low Sexual Desireѻýҕl> Pair of trials demonstrated efficacy in hypoactive sexual desire disorder Feb 03, 2023
<ѻýҕl>Gender-Affirming Hormones Boost Mental Health for Transgender Youthѻýҕl> Gains seen in appearance congruence paired with drops in depression and anxiety, study showed Jan 18, 2023
<ѻýҕl>Short-Course Apalutamide to Reduce Active Surveillance Attrition in Prostate Cancerѻýҕl> Editorialists question whether any intervention violates principles of surveillance Jan 17, 2023
<ѻýҕl>MRI-Guided Focused Ultrasound Eases Pain From Bone Metastasesѻýҕl> More responses with ultrasound, but quality-of-life scores lower vs EBRT in nonrandomized trial Jan 11, 2023
<ѻýҕl>5-ARIs Not Linked to Risk of Dementia Over the Long Termѻýҕl> However, finasteride and dutasteride were associated with an increased risk of depression Dec 22, 2022
<ѻýҕl>One Doc's Win for Trans Youth Healthcare in Texasѻýҕl> A Dallas endocrinologist can continue to provide hormone therapy and puberty blockers Dec 16, 2022
<ѻýҕl>FDA Approves First Gene Therapy for Non-Muscle-Invasive Bladder Cancerѻýҕl> Half of patients achieved complete responses with adenoviral vector-based product Dec 16, 2022
<ѻýҕl>MRI-Targeted Biopsy for Prostate Cancer Reduces Risk of Overdiagnosisѻýҕl> Though at the cost of delayed diagnosis of some clinically significant cancers Dec 07, 2022
<ѻýҕl>Can Oncologists Reduce the Suicide Risk in Their Prostate Cancer Patients?ѻýҕl> Barriers exist in identifying risk, but strategies are available Dec 06, 2022
<ѻýҕl>Aging U.S. Population a Challenge for Oncologistsѻýҕl> Older patients will have different care goals, preferences, geriatric oncologist says Dec 05, 2022
<ѻýҕl>A Dangerous Chilling Effect in Gender-Affirming Careѻýҕl> Gender-affirming facilities must continue offering information and resources, despite threats Dec 03, 2022
<ѻýҕl>To Combat Opioid Epidemic, Step Up Safe Prescribing Practices, Expert Urgesѻýҕl> Overprescribing a continuing problem, Benjamin Davies tells urologists Dec 02, 2022
<ѻýҕl>Pre-Op Axitinib Helps for Partial Nephrectomy of Complex Renal Tumorsѻýҕl> Approach in small ongoing trial resulted in reduction in tumor size and complexity Dec 02, 2022
<ѻýҕl>Sequential Gemcitabine/Docetaxel Promising in NMIBC After BCG Relapseѻýҕl> But patients with BCG-refractory disease may be better suited for cystectomy Dec 02, 2022
<ѻýҕl>Overactive Bladder Linked to Multiple Unmet Socioeconomic Needsѻýҕl> Findings reinforce existing evidence, identify novel factors, suggest future research Dec 01, 2022
<ѻýҕl>Metastasis-Directed Therapy May Delay ADT in Advanced Prostate Cancerѻýҕl> Surgery or radiation delayed initiation of systemic therapy by 18 months Nov 29, 2022
<ѻýҕl>Exercise During Chemo Shows Benefits for Cardiorespiratory Fitnessѻýҕl> However, patients who exercise after chemo also ultimately see benefits too Nov 21, 2022
<ѻýҕl>Youth With Gender Dysphoria Hospitalized for Suicidal Ideation Far More Oftenѻýҕl> Inpatient setting offers unique opportunity to provide gender-affirming care, researchers say Nov 16, 2022
<ѻýҕl>Primary Care Visits Prior to Cancer Diagnosis Tied to Lower Mortalityѻýҕl> Most benefit with annual visits, but even some use linked to better outcomes Nov 16, 2022
<ѻýҕl>Role of Cytoreductive Nephrectomy Unclear for Dedifferentiated Kidney Cancerѻýҕl> Thirteen-month survival gain falls short of statistical significance in observational study Nov 10, 2022
<ѻýҕl>Florida Medical Boards Ban Gender-Affirming Care for Kidsѻýҕl> First state to limit care for trans youth through medical board action Nov 07, 2022
<ѻýҕl>Testosterone Tied to Sustained Weight Loss in Men With Hypogonadism and Obesityѻýҕl> Small data set finds large weight reductions over time Nov 04, 2022
<ѻýҕl>Treatment De-Escalation Shows Promise in Testicular Cancerѻýҕl> Early trial misses primary PFS endpoint, but "favorable" outcomes seen nonetheless Nov 03, 2022